Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

Sandip M. Prasad; William C. Huang; Neal D. Shore; Brian Hu; Marc Bjurlin; Gordon Brown; Pencho Genov; Dimitar Shishkov; Alexandre Khuskivadze; Tosho Ganev; Dobri Marchev; Igor Orlov; Evgeny Kopyltsov; Vadim Zubarev; Alexander Nosov; Dmitrii Komlev; Brent Burger; Sunil Raju; Andrew Meads; Mark Schoenberg

doi:10.1097/JU.0000000000003645

Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

Sandip M. Prasad, William C. Huang, Neal D. Shore, Brian Hu, Marc Bjurlin, Gordon Brown, Pencho Genov, Dimitar Shishkov, Alexandre Khuskivadze, Tosho Ganev, Dobri Marchev, Igor Orlov, Evgeny Kopyltsov, Vadim Zubarev, Alexander Nosov, Dmitrii Komlev, Brent Burger, Sunil Raju, Andrew Meads, Mark Schoenberg

Urology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	619-629
Number of pages	11
Journal	The Journal of urology
Volume	210
Issue number	4
DOIs	https://doi.org/10.1097/JU.0000000000003645
State	Published - Oct 1 2023

ASJC Scopus Subject Areas

Urology

Keywords

ablation techniques
clinical trial
mitomycin
non-muscle invasive bladder neoplasms
phase III

Access to Document

10.1097/JU.0000000000003645

OpenUrl availability

Full text

Cite this

Prasad, S. M., Huang, W. C., Shore, N. D., Hu, B., Bjurlin, M., Brown, G., Genov, P., Shishkov, D., Khuskivadze, A., Ganev, T., Marchev, D., Orlov, I., Kopyltsov, E., Zubarev, V., Nosov, A., Komlev, D., Burger, B., Raju, S., Meads, A., & Schoenberg, M. (2023). Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS). The Journal of urology, 210(4), 619-629. https://doi.org/10.1097/JU.0000000000003645

Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS). / Prasad, Sandip M.; Huang, William C.; Shore, Neal D. et al.
In: The Journal of urology, Vol. 210, No. 4, 01.10.2023, p. 619-629.

Research output: Contribution to journal › Article › peer-review

Prasad, SM, Huang, WC, Shore, ND, Hu, B, Bjurlin, M, Brown, G, Genov, P, Shishkov, D, Khuskivadze, A, Ganev, T, Marchev, D, Orlov, I, Kopyltsov, E, Zubarev, V, Nosov, A, Komlev, D, Burger, B, Raju, S, Meads, A & Schoenberg, M 2023, 'Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)', The Journal of urology, vol. 210, no. 4, pp. 619-629. https://doi.org/10.1097/JU.0000000000003645

Prasad SM, Huang WC, Shore ND, Hu B, Bjurlin M, Brown G et al. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS). The Journal of urology. 2023 Oct 1;210(4):619-629. doi: 10.1097/JU.0000000000003645

Prasad, Sandip M. ; Huang, William C. ; Shore, Neal D. et al. / Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy : A Randomized, Controlled, Phase 3 Trial (ATLAS). In: The Journal of urology. 2023 ; Vol. 210, No. 4. pp. 619-629.

@article{efe520ee3e1a4878abd22444dda348ab,

title = "Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)",

keywords = "ablation techniques, clinical trial, mitomycin, non-muscle invasive bladder neoplasms, phase III",

author = "Prasad, {Sandip M.} and Huang, {William C.} and Shore, {Neal D.} and Brian Hu and Marc Bjurlin and Gordon Brown and Pencho Genov and Dimitar Shishkov and Alexandre Khuskivadze and Tosho Ganev and Dobri Marchev and Igor Orlov and Evgeny Kopyltsov and Vadim Zubarev and Alexander Nosov and Dmitrii Komlev and Brent Burger and Sunil Raju and Andrew Meads and Mark Schoenberg",

year = "2023",

month = oct,

day = "1",

doi = "10.1097/JU.0000000000003645",

language = "English",

volume = "210",

pages = "619--629",

journal = "The Journal of urology",

issn = "0022-5347",

number = "4",

}

TY - JOUR

T1 - Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy

T2 - A Randomized, Controlled, Phase 3 Trial (ATLAS)

AU - Prasad, Sandip M.

AU - Huang, William C.

AU - Shore, Neal D.

AU - Hu, Brian

AU - Bjurlin, Marc

AU - Brown, Gordon

AU - Genov, Pencho

AU - Shishkov, Dimitar

AU - Khuskivadze, Alexandre

AU - Ganev, Tosho

AU - Marchev, Dobri

AU - Orlov, Igor

AU - Kopyltsov, Evgeny

AU - Zubarev, Vadim

AU - Nosov, Alexander

AU - Komlev, Dmitrii

AU - Burger, Brent

AU - Raju, Sunil

AU - Meads, Andrew

AU - Schoenberg, Mark

PY - 2023/10/1

Y1 - 2023/10/1

KW - ablation techniques

KW - clinical trial

KW - mitomycin

KW - non-muscle invasive bladder neoplasms

KW - phase III

UR - http://www.scopus.com/inward/record.url?scp=85170197730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85170197730&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000003645

DO - 10.1097/JU.0000000000003645

M3 - Article

C2 - 37548555

AN - SCOPUS:85170197730

SN - 0022-5347

VL - 210

SP - 619

EP - 629

JO - The Journal of urology

JF - The Journal of urology

IS - 4

ER -

Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this